UNH

In the past six months, UnitedHealth Group's stock has been impacted by several key events. The company reported strong Q1 2026 results, exceeding analyst consensus, leading to a positive shift in investor sentiment. Management raised its full-year 2026 profit forecast and announced plans for AI investments and a share repurchase program. UnitedHealthcare declared it would eliminate most prior authorizations for medical procedures. Despite these positive developments, the stock's 52-week range has been between $234.60 and $390.92, with a 1-year change of -4.10% as of May 7, 2026.